Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment

<i>Background and Objectives</i>: Obstructive sleep apnea (OSA) is common not only in the general population but even more so in patients with tumors of the head and neck region. Untreated, it leads to reduced quality of life, increased daytime sleepiness, and other comorbidities. The ai...

Full description

Bibliographic Details
Main Authors: Olaf Gil, Benjamin Fenske, Thomas Bremert, Marcus Vollmer, Christian Scharf, Chia-Jung Busch, Markus Blaurock
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/2/310
_version_ 1797297578084139008
author Olaf Gil
Benjamin Fenske
Thomas Bremert
Marcus Vollmer
Christian Scharf
Chia-Jung Busch
Markus Blaurock
author_facet Olaf Gil
Benjamin Fenske
Thomas Bremert
Marcus Vollmer
Christian Scharf
Chia-Jung Busch
Markus Blaurock
author_sort Olaf Gil
collection DOAJ
description <i>Background and Objectives</i>: Obstructive sleep apnea (OSA) is common not only in the general population but even more so in patients with tumors of the head and neck region. Untreated, it leads to reduced quality of life, increased daytime sleepiness, and other comorbidities. The aim of this study was to determine the difference in the occurrence of OSA in the patient population with head and neck tumors compared with the general population as represented by the Trend cohort of the Study of Health in Pomerania (SHIP), and to assess the influence of tumor treatment. <i>Materials and Methods</i>: Between July 2018 and December 2021, preoperative polysomnography was conducted in 47 patients with histologically confirmed squamous cell carcinoma in the oropharynx, hypopharynx, or larynx. A follow-up polysomnography was performed in 23 patients 2–11 months after completing treatment. The collected data were correlated with tumor treatment and tumor size. <i>Results:</i> Of the included patients, 43 were male and 4 were female. Age ranged from 54 to 90 years. The pretherapeutic measurement found no significant difference in the prevalence of a pathologically elevated apnea–hypopnea index (AHI) in our patients compared with the SHIP Trend cohort. In the follow-up measurement after completion of treartment, a significant deterioration in AHI was observed. Initially, 70% of patients had an AHI > 5; after therapy, this increased to 87% (<i>p</i> = 0.008). The effect was particularly pronounced in the group of patients with advanced tumor stages who had received primary chemoradiation. <i>Conclusions</i>: OSA is a relevant condition in patients with head and neck cancer. Tumor treatment can lead to an increased occurrence of sleep-related breathing disorders, especially in patients with advanced tumor stages undergoing primary chemoradiation. Additional studies are necessary to better understand the exact mechanism involved.
first_indexed 2024-03-07T22:22:22Z
format Article
id doaj.art-f40c0e84b447459494990c1a0f5410b6
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-07T22:22:22Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-f40c0e84b447459494990c1a0f5410b62024-02-23T15:26:43ZengMDPI AGMedicina1010-660X1648-91442024-02-0160231010.3390/medicina60020310Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after TreatmentOlaf Gil0Benjamin Fenske1Thomas Bremert2Marcus Vollmer3Christian Scharf4Chia-Jung Busch5Markus Blaurock6Department of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, GermanyDepartment of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, GermanyDepartment of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, GermanyInstitute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, GermanyDepartment of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, GermanyDepartment of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, GermanyDepartment of Otorhinolaryngology, University Medicine Greifswald, 17475 Greifswald, Germany<i>Background and Objectives</i>: Obstructive sleep apnea (OSA) is common not only in the general population but even more so in patients with tumors of the head and neck region. Untreated, it leads to reduced quality of life, increased daytime sleepiness, and other comorbidities. The aim of this study was to determine the difference in the occurrence of OSA in the patient population with head and neck tumors compared with the general population as represented by the Trend cohort of the Study of Health in Pomerania (SHIP), and to assess the influence of tumor treatment. <i>Materials and Methods</i>: Between July 2018 and December 2021, preoperative polysomnography was conducted in 47 patients with histologically confirmed squamous cell carcinoma in the oropharynx, hypopharynx, or larynx. A follow-up polysomnography was performed in 23 patients 2–11 months after completing treatment. The collected data were correlated with tumor treatment and tumor size. <i>Results:</i> Of the included patients, 43 were male and 4 were female. Age ranged from 54 to 90 years. The pretherapeutic measurement found no significant difference in the prevalence of a pathologically elevated apnea–hypopnea index (AHI) in our patients compared with the SHIP Trend cohort. In the follow-up measurement after completion of treartment, a significant deterioration in AHI was observed. Initially, 70% of patients had an AHI > 5; after therapy, this increased to 87% (<i>p</i> = 0.008). The effect was particularly pronounced in the group of patients with advanced tumor stages who had received primary chemoradiation. <i>Conclusions</i>: OSA is a relevant condition in patients with head and neck cancer. Tumor treatment can lead to an increased occurrence of sleep-related breathing disorders, especially in patients with advanced tumor stages undergoing primary chemoradiation. Additional studies are necessary to better understand the exact mechanism involved.https://www.mdpi.com/1648-9144/60/2/310tumorsleep-related breathing disordershead and neck cancerobstructive sleep apnea
spellingShingle Olaf Gil
Benjamin Fenske
Thomas Bremert
Marcus Vollmer
Christian Scharf
Chia-Jung Busch
Markus Blaurock
Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
Medicina
tumor
sleep-related breathing disorders
head and neck cancer
obstructive sleep apnea
title Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
title_full Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
title_fullStr Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
title_full_unstemmed Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
title_short Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment
title_sort prevalence of obstructive sleep apnea in head and neck squamous cell carcinoma patients before and after treatment
topic tumor
sleep-related breathing disorders
head and neck cancer
obstructive sleep apnea
url https://www.mdpi.com/1648-9144/60/2/310
work_keys_str_mv AT olafgil prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT benjaminfenske prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT thomasbremert prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT marcusvollmer prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT christianscharf prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT chiajungbusch prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment
AT markusblaurock prevalenceofobstructivesleepapneainheadandnecksquamouscellcarcinomapatientsbeforeandaftertreatment